Perry Karsen - Profile and Investment Details

Investor Profile

Perry Karsen is a Venture Capital, Investor based in San Francisco, California, United States with a diverse investment portfolio that includes companies such as Intellia Therapeutics, Inc., Abbott, Genentech, Jounce Therapeutics, Inc., Graphite Bio, Voyager Therapeutics, Inc., Samsara BioCapital, Pliant Therapeutics, Agios Pharmaceuticals, ESCAPE Bio, OncoMed Pharmaceuticals, . Over time, Perry Karsen has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Perry Karsen is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Autoimmune Diseases, Wellness, Engineering, Biotechnology, Electronic Health Records (EHR), Health and Hospital Services, Research, Medical, B2B, Pharmaceuticals may find it worthwhile to explore potential connections with Perry Karsen, as their portfolio suggests a familiarity and interest in this area.

Understanding Perry Karsen’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.